Dosimetry Group: Evaluation of Percentage of Injected Dose Reaching the Target (TACs) in Organs
[68Ga]-NeoBOMB1 Imaging in Patients With Malignancies Known to Overexpress Gastrin Releasing Peptide Receptor (GRPR) · Source last updated 2020-10-23
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
Measure
NUMBER
Unit
%ID/g
Interval / dispersion
Not reported
Time frame
[68Ga]-NeoBOMB1 PET imaging acquired at Day 1 (0.15, 1.00, 2.00 and 4.00 hours)
What was measured
For patients included in the dosimetry group, the percentage of injected dose per gram of tissue (%ID/g) reaching source organs was to be calculated using the acquired PET images at each time point. The resulting TACs were to be summarized descriptively.
Analysis population: Full Analysis Set (FAS). Dosimetry group targeted participants with Breast Cancer and Prostate Cancer, but only 2 participants from Breast Cancer arm enrolled in the Dosimetry Group. Due to the sample size in the dosimetry group (2 patients), summary statistics were not performed.
Groups in this outcome
Breast
All eligible participants were to receive recommended dose of \[68Ga\]-NeoBOMB1 of 3 Mega Becquerel (MBq)/Kg (+/- 10%) \[but not more than 250 and not less than 150 MBq. The maximum peptide mass administered was 50 microgram (µg)\].
Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.
Analysis denominator · Participants
Group
Source count
Breast
2
Reported measurements
Participant 1: 15 min post-dose (Bladder)
Analysis denominator · Participants
Group
Source count
Breast
1
Values in %ID/g · Interval/dispersion: Not reported
Group
Value
Spread
Lower
Upper
Comment
Breast
0.03132
Not reported
Not reported
Not reported
Not reported
Participant 1: 15 min post-dose (Heart)
Analysis denominator · Participants
Group
Source count
Breast
1
Values in %ID/g · Interval/dispersion: Not reported
Group
Value
Spread
Lower
Upper
Comment
Breast
0.00600
Not reported
Not reported
Not reported
Not reported
Participant 1: 15 min post-dose (Kidney)
Analysis denominator · Participants
Group
Source count
Breast
1
Values in %ID/g · Interval/dispersion: Not reported
Group
Value
Spread
Lower
Upper
Comment
Breast
0.00688
Not reported
Not reported
Not reported
Not reported
Participant 1: 15 min post-dose (Liver)
Analysis denominator · Participants
Group
Source count
Breast
1
Values in %ID/g · Interval/dispersion: Not reported
Group
Value
Spread
Lower
Upper
Comment
Breast
0.00794
Not reported
Not reported
Not reported
Not reported
Participant 1: 15 min post-dose (Lung)
Analysis denominator · Participants
Group
Source count
Breast
1
Values in %ID/g · Interval/dispersion: Not reported
Group
Value
Spread
Lower
Upper
Comment
Breast
0.00218
Not reported
Not reported
Not reported
Not reported
Participant 1: 15 min post-dose (Marrow)
Analysis denominator · Participants
Group
Source count
Breast
1
Values in %ID/g · Interval/dispersion: Not reported
Group
Value
Spread
Lower
Upper
Comment
Breast
0.00331
Not reported
Not reported
Not reported
Not reported
Participant 1: 15 min post-dose (Pancreas)
Analysis denominator · Participants
Group
Source count
Breast
1
Values in %ID/g · Interval/dispersion: Not reported
Group
Value
Spread
Lower
Upper
Comment
Breast
0.04711
Not reported
Not reported
Not reported
Not reported
Participant 1: 15 min post-dose (Spleen)
Analysis denominator · Participants
Group
Source count
Breast
1
Values in %ID/g · Interval/dispersion: Not reported
Group
Value
Spread
Lower
Upper
Comment
Breast
0.00409
Not reported
Not reported
Not reported
Not reported
Participant 1: 1 hour post-dose (Bladder)
Analysis denominator · Participants
Group
Source count
Breast
1
Values in %ID/g · Interval/dispersion: Not reported
Group
Value
Spread
Lower
Upper
Comment
Breast
0.04259
Not reported
Not reported
Not reported
Not reported
Participant 1: 1 hour post-dose (Heart)
Analysis denominator · Participants
Group
Source count
Breast
1
Values in %ID/g · Interval/dispersion: Not reported
Group
Value
Spread
Lower
Upper
Comment
Breast
0.00241
Not reported
Not reported
Not reported
Not reported
Participant 1: 1 hour post-dose (Kidney)
Analysis denominator · Participants
Group
Source count
Breast
1
Values in %ID/g · Interval/dispersion: Not reported
Group
Value
Spread
Lower
Upper
Comment
Breast
0.00577
Not reported
Not reported
Not reported
Not reported
Participant 1: 1 hour post-dose (Liver)
Analysis denominator · Participants
Group
Source count
Breast
1
Values in %ID/g · Interval/dispersion: Not reported
Group
Value
Spread
Lower
Upper
Comment
Breast
0.00296
Not reported
Not reported
Not reported
Not reported
Participant 1: 1 hour post-dose (Lung)
Analysis denominator · Participants
Group
Source count
Breast
1
Values in %ID/g · Interval/dispersion: Not reported
Group
Value
Spread
Lower
Upper
Comment
Breast
0.00095
Not reported
Not reported
Not reported
Not reported
Participant 1: 1 hour post-dose (Marrow)
Analysis denominator · Participants
Group
Source count
Breast
1
Values in %ID/g · Interval/dispersion: Not reported
Group
Value
Spread
Lower
Upper
Comment
Breast
0.00116
Not reported
Not reported
Not reported
Not reported
Participant 1: 1 hour post-dose (Pancreas)
Analysis denominator · Participants
Group
Source count
Breast
1
Values in %ID/g · Interval/dispersion: Not reported
Group
Value
Spread
Lower
Upper
Comment
Breast
0.04836
Not reported
Not reported
Not reported
Not reported
Participant 1: 1 hour post-dose (Spleen)
Analysis denominator · Participants
Group
Source count
Breast
1
Values in %ID/g · Interval/dispersion: Not reported
Group
Value
Spread
Lower
Upper
Comment
Breast
0.00211
Not reported
Not reported
Not reported
Not reported
Participant 1: 2 hours post-dose (Bladder)
Analysis denominator · Participants
Group
Source count
Breast
1
Values in %ID/g · Interval/dispersion: Not reported
Group
Value
Spread
Lower
Upper
Comment
Breast
0.02141
Not reported
Not reported
Not reported
Not reported
Participant 1: 2 hours post-dose (Heart)
Analysis denominator · Participants
Group
Source count
Breast
1
Values in %ID/g · Interval/dispersion: Not reported
Group
Value
Spread
Lower
Upper
Comment
Breast
0.00163
Not reported
Not reported
Not reported
Not reported
Participant 1: 2 hours post-dose (Kidney)
Analysis denominator · Participants
Group
Source count
Breast
1
Values in %ID/g · Interval/dispersion: Not reported
Group
Value
Spread
Lower
Upper
Comment
Breast
0.00239
Not reported
Not reported
Not reported
Not reported
Participant 1: 2 hours post-dose (Liver)
Analysis denominator · Participants
Group
Source count
Breast
1
Values in %ID/g · Interval/dispersion: Not reported
Group
Value
Spread
Lower
Upper
Comment
Breast
0.00197
Not reported
Not reported
Not reported
Not reported
Participant 1: 2 hours post-dose (Lung)
Analysis denominator · Participants
Group
Source count
Breast
1
Values in %ID/g · Interval/dispersion: Not reported
Group
Value
Spread
Lower
Upper
Comment
Breast
0.00068
Not reported
Not reported
Not reported
Not reported
Participant 1: 2 hours post-dose (Marrow)
Analysis denominator · Participants
Group
Source count
Breast
1
Values in %ID/g · Interval/dispersion: Not reported
Group
Value
Spread
Lower
Upper
Comment
Breast
0.00092
Not reported
Not reported
Not reported
Not reported
Participant 1: 2 hours post-dose (Pancreas)
Analysis denominator · Participants
Group
Source count
Breast
1
Values in %ID/g · Interval/dispersion: Not reported
Group
Value
Spread
Lower
Upper
Comment
Breast
0.05445
Not reported
Not reported
Not reported
Not reported
Participant 1: 2 hours post-dose (Spleen)
Analysis denominator · Participants
Group
Source count
Breast
1
Values in %ID/g · Interval/dispersion: Not reported
Group
Value
Spread
Lower
Upper
Comment
Breast
0.00141
Not reported
Not reported
Not reported
Not reported
Participant 1: 4 hours post-dose (Bladder)
Analysis denominator · Participants
Group
Source count
Breast
1
Values in %ID/g · Interval/dispersion: Not reported
Group
Value
Spread
Lower
Upper
Comment
Breast
0.01790
Not reported
Not reported
Not reported
Not reported
Participant 1: 4 hours post-dose (Heart)
Analysis denominator · Participants
Group
Source count
Breast
1
Values in %ID/g · Interval/dispersion: Not reported
Group
Value
Spread
Lower
Upper
Comment
Breast
0.00130
Not reported
Not reported
Not reported
Not reported
Participant 1: 4 hours post-dose (Kidney)
Analysis denominator · Participants
Group
Source count
Breast
1
Values in %ID/g · Interval/dispersion: Not reported
Group
Value
Spread
Lower
Upper
Comment
Breast
0.00149
Not reported
Not reported
Not reported
Not reported
Participant 1: 4 hours post-dose (Liver)
Analysis denominator · Participants
Group
Source count
Breast
1
Values in %ID/g · Interval/dispersion: Not reported
Group
Value
Spread
Lower
Upper
Comment
Breast
0.00162
Not reported
Not reported
Not reported
Not reported
Participant 1: 4 hours post-dose (Lung)
Analysis denominator · Participants
Group
Source count
Breast
1
Values in %ID/g · Interval/dispersion: Not reported
Group
Value
Spread
Lower
Upper
Comment
Breast
0.00062
Not reported
Not reported
Not reported
Not reported
Participant 1: 4 hours post-dose (Marrow)
Analysis denominator · Participants
Group
Source count
Breast
1
Values in %ID/g · Interval/dispersion: Not reported
Group
Value
Spread
Lower
Upper
Comment
Breast
0.00035
Not reported
Not reported
Not reported
Not reported
Participant 1: 4 hours post-dose (Pancreas)
Analysis denominator · Participants
Group
Source count
Breast
1
Values in %ID/g · Interval/dispersion: Not reported
Group
Value
Spread
Lower
Upper
Comment
Breast
0.06280
Not reported
Not reported
Not reported
Not reported
Participant 1: 4 hours post-dose (Spleen)
Analysis denominator · Participants
Group
Source count
Breast
1
Values in %ID/g · Interval/dispersion: Not reported
Group
Value
Spread
Lower
Upper
Comment
Breast
0.00120
Not reported
Not reported
Not reported
Not reported
Participant 2: 15 min post-dose (Bladder)
Analysis denominator · Participants
Group
Source count
Breast
1
Values in %ID/g · Interval/dispersion: Not reported
Group
Value
Spread
Lower
Upper
Comment
Breast
0.02682
Not reported
Not reported
Not reported
Not reported
Participant 2: 15 min post-dose (Heart)
Analysis denominator · Participants
Group
Source count
Breast
1
Values in %ID/g · Interval/dispersion: Not reported
Group
Value
Spread
Lower
Upper
Comment
Breast
0.00340
Not reported
Not reported
Not reported
Not reported
Participant 2: 15 min post-dose (Kidney)
Analysis denominator · Participants
Group
Source count
Breast
1
Values in %ID/g · Interval/dispersion: Not reported
Group
Value
Spread
Lower
Upper
Comment
Breast
0.00480
Not reported
Not reported
Not reported
Not reported
Participant 2: 15 min post-dose (Liver)
Analysis denominator · Participants
Group
Source count
Breast
1
Values in %ID/g · Interval/dispersion: Not reported
Group
Value
Spread
Lower
Upper
Comment
Breast
0.00866
Not reported
Not reported
Not reported
Not reported
Participant 2: 15 min post-dose (Lung)
Analysis denominator · Participants
Group
Source count
Breast
1
Values in %ID/g · Interval/dispersion: Not reported
Group
Value
Spread
Lower
Upper
Comment
Breast
0.00124
Not reported
Not reported
Not reported
Not reported
Participant 2: 15 min post-dose (Marrow)
Analysis denominator · Participants
Group
Source count
Breast
1
Values in %ID/g · Interval/dispersion: Not reported
Group
Value
Spread
Lower
Upper
Comment
Breast
0.00186
Not reported
Not reported
Not reported
Not reported
Participant 2: 15 min post-dose (Pancreas)
Analysis denominator · Participants
Group
Source count
Breast
1
Values in %ID/g · Interval/dispersion: Not reported
Group
Value
Spread
Lower
Upper
Comment
Breast
0.02146
Not reported
Not reported
Not reported
Not reported
Participant 2: 15 min post-dose (Spleen)
Analysis denominator · Participants
Group
Source count
Breast
1
Values in %ID/g · Interval/dispersion: Not reported
Group
Value
Spread
Lower
Upper
Comment
Breast
0.00338
Not reported
Not reported
Not reported
Not reported
Participant 2: 1 hour post-dose (Bladder)
Analysis denominator · Participants
Group
Source count
Breast
1
Values in %ID/g · Interval/dispersion: Not reported
Group
Value
Spread
Lower
Upper
Comment
Breast
0.06480
Not reported
Not reported
Not reported
Not reported
Participant 2: 1 hour post-dose (Heart)
Analysis denominator · Participants
Group
Source count
Breast
1
Values in %ID/g · Interval/dispersion: Not reported
Group
Value
Spread
Lower
Upper
Comment
Breast
0.00207
Not reported
Not reported
Not reported
Not reported
Participant 2: 1 hour post-dose (Kidney)
Analysis denominator · Participants
Group
Source count
Breast
1
Values in %ID/g · Interval/dispersion: Not reported
Group
Value
Spread
Lower
Upper
Comment
Breast
0.00380
Not reported
Not reported
Not reported
Not reported
Participant 2: 1 hour post-dose (Liver)
Analysis denominator · Participants
Group
Source count
Breast
1
Values in %ID/g · Interval/dispersion: Not reported
Group
Value
Spread
Lower
Upper
Comment
Breast
0.00564
Not reported
Not reported
Not reported
Not reported
Participant 2: 1 hour post-dose (Lung)
Analysis denominator · Participants
Group
Source count
Breast
1
Values in %ID/g · Interval/dispersion: Not reported
Group
Value
Spread
Lower
Upper
Comment
Breast
0.00088
Not reported
Not reported
Not reported
Not reported
Participant 2: 1 hour post-dose (Marrow)
Analysis denominator · Participants
Group
Source count
Breast
1
Values in %ID/g · Interval/dispersion: Not reported
Group
Value
Spread
Lower
Upper
Comment
Breast
0.00136
Not reported
Not reported
Not reported
Not reported
Participant 2: 1 hour post-dose (Pancreas)
Analysis denominator · Participants
Group
Source count
Breast
1
Values in %ID/g · Interval/dispersion: Not reported
Group
Value
Spread
Lower
Upper
Comment
Breast
0.02909
Not reported
Not reported
Not reported
Not reported
Participant 2: 1 hour post-dose (Spleen)
Analysis denominator · Participants
Group
Source count
Breast
1
Values in %ID/g · Interval/dispersion: Not reported
Group
Value
Spread
Lower
Upper
Comment
Breast
0.00256
Not reported
Not reported
Not reported
Not reported
Participant 2: 2 hours post-dose (Bladder)
Analysis denominator · Participants
Group
Source count
Breast
1
Values in %ID/g · Interval/dispersion: Not reported
Group
Value
Spread
Lower
Upper
Comment
Breast
0.04055
Not reported
Not reported
Not reported
Not reported
Participant 2: 2 hours post-dose (Heart)
Analysis denominator · Participants
Group
Source count
Breast
1
Values in %ID/g · Interval/dispersion: Not reported
Group
Value
Spread
Lower
Upper
Comment
Breast
0.00142
Not reported
Not reported
Not reported
Not reported
Participant 2: 2 hours post-dose (Kidney)
Analysis denominator · Participants
Group
Source count
Breast
1
Values in %ID/g · Interval/dispersion: Not reported
Group
Value
Spread
Lower
Upper
Comment
Breast
0.00505
Not reported
Not reported
Not reported
Not reported
Participant 2: 2 hours post-dose (Liver)
Analysis denominator · Participants
Group
Source count
Breast
1
Values in %ID/g · Interval/dispersion: Not reported
Group
Value
Spread
Lower
Upper
Comment
Breast
0.00428
Not reported
Not reported
Not reported
Not reported
Participant 2: 2 hours post-dose (Lung)
Analysis denominator · Participants
Group
Source count
Breast
1
Values in %ID/g · Interval/dispersion: Not reported
Group
Value
Spread
Lower
Upper
Comment
Breast
0.00059
Not reported
Not reported
Not reported
Not reported
Participant 2: 2 hours post-dose (Marrow)
Analysis denominator · Participants
Group
Source count
Breast
1
Values in %ID/g · Interval/dispersion: Not reported
Group
Value
Spread
Lower
Upper
Comment
Breast
0.00100
Not reported
Not reported
Not reported
Not reported
Participant 2: 2 hours post-dose (Pancreas)
Analysis denominator · Participants
Group
Source count
Breast
1
Values in %ID/g · Interval/dispersion: Not reported
Group
Value
Spread
Lower
Upper
Comment
Breast
0.03450
Not reported
Not reported
Not reported
Not reported
Participant 2: 2 hours post-dose (Spleen)
Analysis denominator · Participants
Group
Source count
Breast
1
Values in %ID/g · Interval/dispersion: Not reported
Group
Value
Spread
Lower
Upper
Comment
Breast
0.00191
Not reported
Not reported
Not reported
Not reported
Participant 2: 4 hours post-dose (Bladder)
Analysis denominator · Participants
Group
Source count
Breast
1
Values in %ID/g · Interval/dispersion: Not reported
Group
Value
Spread
Lower
Upper
Comment
Breast
0.11045
Not reported
Not reported
Not reported
Not reported
Participant 2: 4 hours post-dose (Heart)
Analysis denominator · Participants
Group
Source count
Breast
1
Values in %ID/g · Interval/dispersion: Not reported
Group
Value
Spread
Lower
Upper
Comment
Breast
0.00093
Not reported
Not reported
Not reported
Not reported
Participant 2: 4 hours post-dose (Kidney)
Analysis denominator · Participants
Group
Source count
Breast
1
Values in %ID/g · Interval/dispersion: Not reported
Group
Value
Spread
Lower
Upper
Comment
Breast
0.00278
Not reported
Not reported
Not reported
Not reported
Participant 2: 4 hours post-dose (Liver)
Analysis denominator · Participants
Group
Source count
Breast
1
Values in %ID/g · Interval/dispersion: Not reported
Group
Value
Spread
Lower
Upper
Comment
Breast
0.00317
Not reported
Not reported
Not reported
Not reported
Participant 2: 4 hours post-dose (Lung)
Analysis denominator · Participants
Group
Source count
Breast
1
Values in %ID/g · Interval/dispersion: Not reported
Group
Value
Spread
Lower
Upper
Comment
Breast
0.00039
Not reported
Not reported
Not reported
Not reported
Participant 2: 4 hours post-dose (Marrow)
Analysis denominator · Participants
Group
Source count
Breast
1
Values in %ID/g · Interval/dispersion: Not reported
Group
Value
Spread
Lower
Upper
Comment
Breast
0.00072
Not reported
Not reported
Not reported
Not reported
Participant 2: 4 hours post-dose (Pancreas)
Analysis denominator · Participants
Group
Source count
Breast
1
Values in %ID/g · Interval/dispersion: Not reported
Group
Value
Spread
Lower
Upper
Comment
Breast
0.03745
Not reported
Not reported
Not reported
Not reported
Participant 2: 4 hours post-dose (Spleen)
Analysis denominator · Participants
Group
Source count
Breast
1
Values in %ID/g · Interval/dispersion: Not reported
Group
Value
Spread
Lower
Upper
Comment
Breast
0.00145
Not reported
Not reported
Not reported
Not reported
Complete source fields
classes
categories
measurements
group Id
OG000
value
0.03132
denoms
counts
group Id
OG000
value
1
units
Participants
title
Participant 1: 15 min post-dose (Bladder)
categories
measurements
group Id
OG000
value
0.00600
denoms
counts
group Id
OG000
value
1
units
Participants
title
Participant 1: 15 min post-dose (Heart)
categories
measurements
group Id
OG000
value
0.00688
denoms
counts
group Id
OG000
value
1
units
Participants
title
Participant 1: 15 min post-dose (Kidney)
categories
measurements
group Id
OG000
value
0.00794
denoms
counts
group Id
OG000
value
1
units
Participants
title
Participant 1: 15 min post-dose (Liver)
categories
measurements
group Id
OG000
value
0.00218
denoms
counts
group Id
OG000
value
1
units
Participants
title
Participant 1: 15 min post-dose (Lung)
categories
measurements
group Id
OG000
value
0.00331
denoms
counts
group Id
OG000
value
1
units
Participants
title
Participant 1: 15 min post-dose (Marrow)
categories
measurements
group Id
OG000
value
0.04711
denoms
counts
group Id
OG000
value
1
units
Participants
title
Participant 1: 15 min post-dose (Pancreas)
categories
measurements
group Id
OG000
value
0.00409
denoms
counts
group Id
OG000
value
1
units
Participants
title
Participant 1: 15 min post-dose (Spleen)
categories
measurements
group Id
OG000
value
0.04259
denoms
counts
group Id
OG000
value
1
units
Participants
title
Participant 1: 1 hour post-dose (Bladder)
categories
measurements
group Id
OG000
value
0.00241
denoms
counts
group Id
OG000
value
1
units
Participants
title
Participant 1: 1 hour post-dose (Heart)
categories
measurements
group Id
OG000
value
0.00577
denoms
counts
group Id
OG000
value
1
units
Participants
title
Participant 1: 1 hour post-dose (Kidney)
categories
measurements
group Id
OG000
value
0.00296
denoms
counts
group Id
OG000
value
1
units
Participants
title
Participant 1: 1 hour post-dose (Liver)
denoms
counts
group Id
OG000
value
2
units
Participants
description
For patients included in the dosimetry group, the percentage of injected dose per gram of tissue (%ID/g) reaching source organs was to be calculated using the acquired PET images at each time point. The resulting TACs were to be summarized descriptively.
groups
description
All eligible participants were to receive recommended dose of \[68Ga\]-NeoBOMB1 of 3 Mega Becquerel (MBq)/Kg (+/- 10%) \[but not more than 250 and not less than 150 MBq. The maximum peptide mass administered was 50 microgram (µg)\].
id
OG000
title
Breast
param Type
NUMBER
population Description
Full Analysis Set (FAS). Dosimetry group targeted participants with Breast Cancer and Prostate Cancer, but only 2 participants from Breast Cancer arm enrolled in the Dosimetry Group. Due to the sample size in the dosimetry group (2 patients), summary statistics were not performed.
reporting Status
POSTED
time Frame
[68Ga]-NeoBOMB1 PET imaging acquired at Day 1 (0.15, 1.00, 2.00 and 4.00 hours)
title
Dosimetry Group: Evaluation of Percentage of Injected Dose Reaching the Target (TACs) in Organs